Initial fetal platelet counts predict the response to intravenous gammaglobulin therapy in fetuses that are affected by PLA1 incompatibility.
D000328:Adult; D016824:Antigens, Human Platelet / Q000097:blood*; D001327:Autoimmune Diseases / Q000097:blood / Q000151:congenital / Q000188:drug therapy / Q000276:immunology; D005260:Female; D005315:Fetal Diseases / Q000097:blood* / Q000188:drug therapy* / Q000276:immunology; D005500:Follow-Up Studies; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000627:therapeutic use*; D039661:Integrin beta3; D008875:Middle Aged; D010976:Platelet Count; D011237:Predictive Value of Tests; D011247:Pregnancy; D011295:Prenatal Care; D011336:Probability; D012189:Retrospective Studies; D012680:Sensitivity and Specificity; D013256:Steroids / Q000008:administration & dosage; D013921:Thrombocytopenia / Q000097:blood* / Q000151:congenital / Q000188:drug therapy* / Q000276:immunology; D016896:Treatment Outcome